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Abstract
The restless legs syndrome (RLS) is a common sensorimotor condition that often results in discomfort and sleep disturbance. Diagnosis of RLS is entirely clinical and
based upon a patient’s description of subjective symptoms, and thus when considering RLS diagnosis non-specificity is a real problem. RLS is associated with
periodic limb movements during sleep (PLMS) in up to 90% of RLS sufferers; however, their presence is neither sufficient nor necessary for the diagnosis of RLS.
The disease RLS and the motor phenomenon of PLMS share similarities in various areas, which include pathophysiology, pharmacology, genetics, and
epidemiology. The purpose of this opinion piece is to outline the many similarities between RLS and PLMS in order to make an argument for the inclusion of
PLMS as a supplementary diagnostic criterion of RLS, termed electro-clinical RLS, which would consist of the current clinical RLS diagnosis plus PLMS. This
additional criterion could be used in cases where diagnosis is unclear to increase specificity or in research projects where proper diagnosis is desired at the
investigational level.
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Introduction
The restless legs syndrome (RLS) is a dysesthetic neurologic
condition consisting of an inexorable urge to move the legs, occurring
during inactivity and at night, when rest is most desired. RLS is
clinically significant, especially when severe, as it causes sleep
disturbance, and is associated with both depression and cardiovascular
disease.1–3 These associations are of interest to public health as RLS is
a common disease, with a prevalence in North America and Europe
between 5% and 10%.4 Although the pathophysiology of RLS is not
entirely clear, dysfunction in the A11 dopaminergic system and
impaired brain iron homeostasis are likely important mechanisms
underlying this troublesome disease.5,6
RLS is classified among the sleep-related movement disorders, even
though abnormal movement is neither necessary nor sufficient to
diagnose this condition. Despite this, abnormal movements do occur in
the form of periodic limb movements during sleep (PLMS) in as many
as 90% of RLS sufferers.1 PLMS consist of brisk foot and knee flexive
movements, occurring every 20–40 seconds during sleep.7 Without
considering these movements, the diagnosis of RLS is made on the
basis of the presence, timing, and characteristics of subjective
symptoms, and the absence of conditions that can ‘‘mimic’’ RLS.8,9
Because diagnosis of RLS is based on historical symptoms, both
sensitivity and specificity are largely variable depending on the
experience and knowledge of the practitioner retrieving this informa-
tion. Therefore, in clinical practice, where there are practitioners of
varying levels of experience, misdiagnosis of RLS is common (author’s
experience).
When considering screening for RLS in research, an interview is
often replaced by a questionnaire that screens for RLS. The use of a
questionnaire eliminates the factor of interviewer experience and
knowledge, but adds variability in that questions often differ from one
questionnaire to the next. This issue of questionnaire variability is very
problematic when trying to make inferences across different epide-
miologic studies that have estimated RLS prevalence.10 Thus, current
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methods used to diagnose RLS in both clinical and investigational
settings, are tool- and operator dependent, compromising both
sensitivity and specificity.
In addition to occurring in the majority of patients with RLS, PLMS
and their frequency correlate with the severity of RLS and respond to
medical treatment similarly to the sensory symptoms of RLS, arguing
for shared pathophysiology.11,12 The purpose of this monograph is to
briefly outline common pitfalls in the diagnosis of RLS, then to
describe important adjoining features of RLS and PLMS in areas of
pathophysiology, genetics, pharmacology, epidemiology, and clinical
relevance, and finally to make an argument for the inclusion of PLMS
measurement in the diagnosis of RLS.
Pitfalls in RLS diagnosis
In 2003, the International RLS Study Group (IRLSSG) published
the minimum criteria necessary to diagnose RLS, which included 1) an
urge to move the legs, usually accompanied by uncomfortable
sensations, 2) the urge to move or unpleasant sensations begin or
worsen during periods of rest or inactivity, 3) the urge to move or
unpleasant sensations are partially or completely relieved by move-
ment, and 4) worsening of symptoms in the evening or night.13 In
2014, these criteria were amended to include a fifth essential criterion,
differential diagnosis, to decrease the chances that RLS symptoms
would be confused with similar symptoms from other conditions
(Table 1).8 In fact, the need to differentiate RLS from entities that can
mimic RLS is likely the biggest pitfall of RLS diagnosis, as the ability to
do so depends highly on the experience of the information retriever,
not only with RLS itself, but with other conditions that mimic RLS,
including peripheral neuropathy and nocturnal leg cramps. So the
specificity of RLS diagnosis is likely to vary greatly among different
operators, depending on experience and the inquisitiveness to ask
about other conditions. Clearly, experience varies greatly in the clinical
realm where practitioners have varying years of experience, types of
education (physician vs. nurse), and areas of expertise (neurologist vs.
internist). In research, RLS screening is often conducted by ‘‘trained’’
research assistants who may have no specific training in diagnosing
conditions that may mimic RLS.
The diagnosis of RLS is contingent on an accurate and clear
description or history. Inherently, sensations associated with RLS
symptoms are difficult to describe, often making this a challenge for
patients. Still, patients must be able to articulate symptoms and should be
asked to describe the RLS symptoms in their own words. The ability to
accurately characterize symptoms clearly differs among patients, and this
variation compromises both specificity and sensitivity.
RLS can also be diagnosed by questionnaire. The advantage of
using a questionnaire to diagnose RLS is that operator experience is no
longer an issue. The four core RLS criteria can easily be formatted
into a questionnaire, and, to date, this is the most common means by
which RLS has been determined in epidemiologic studies to estimate
prevalence.10 Unfortunately, across studies, the wording of these
questions has varied, and, at times, the four criteria have been
screened in three or fewer questions.14,15 Furthermore, questions to
rule out RLS mimics have scarcely been used. There is only one
validated questionnaire that includes IRLSSG criteria and items that
screen for RLS mimics: the Cambridge–Hopkins RLS questionnaire.16
In sum, these pitfalls negatively affect both sensitivity and specificity
in accurately diagnosing RLS, the main problem being specificity. The
addition of an objective-qualifying criterion, such as the presence of
PLMS, would help to increase specificity in the diagnosis of RLS.
Interconnected pathophysiology?
Although definitive pathophysiologic mechanisms have not been
elucidated for either RLS or PLMS, preliminary work suggests that
these two entities share common pathophysiologic origins. PLMS are
seen in 80–90% of persons with RLS.1 While awake, periodic
movements are often preceded by sensory discomfort or an urge to
move, and both involuntary movement and sensory discomfort can be
aborted if voluntary movement (e.g., walking) occurs.17
PLMS are thought to arise from a spinal generator as affected
muscles are activated in a rostral to caudal or caudal to rostral fashion
(e.g., L4RL5RS1 or S1RL5RL4).17 Dopaminergic A11 neurons
originating in the hypothalamus and projecting throughout the spinal
cord have been implicated in animal models of RLS.5,18 Neurons in
this dopaminergic A11 system synapse in thalamic nuclei before
eventually projecting to the spinal cord.19 The medial thalamus has
been implicated as an important structure in the pathogenesis of RLS,
showing decreased connectivity and reduced metabolism in functional
imaging studies.20,21 These studies suggest that the symptoms of RLS
may evolve into the movements of PLMS through a diencephalic
disinhibition phenomenon, which activates a spinal movement
generator.
Pharmacology
Dopaminergic dysfunction may underlie both RLS and PLMS.
Similarity in the neuro-chemical basis of RLS and PLMS is supported
by the pharmacology of these two entities. It has been known for some
time that dopamine agonist medication effectively treats the symptoms
of RLS.24 In addition to ameliorating the sensory discomfort of RLS,
dopamine agonists significantly decrease the number of PLMS
observed at night and can even reduce PLMS when RLS is not
present (such as PLMS in narcolepsy).25,26 Drugs that preferentially
target the D3 receptor subtype, including pramipexole, compared with
those that target the D2 receptor subtype, bromocriptine, have greater
efficacy in reducing both RLS symptoms and PLMS.27
PLMS seem to arise or become more frequent with the use of many
antidepressant medications, including tricyclic antidepressants, fluox-
etine, and venlafaxine but not buproprion.28,29 Similarly, antidepres-
sant medications can worsen the severity of RLS symptoms, again
arguing for shared pharmacology and thus pathophysiology of RLS
and PLMS.30
Genetics
Genome-wide association studies have identified that RLS is
associated with genetic variants or single nucleotide polymorphisms
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on the following genes: BTBD9 on chromosome 6, MEIS1 on
chromosome 2, mitogen-activated protein kinase kinase 5 (MAP2K5)/
Ladybird Homeobox Co-repressor 1 (LBXCOR1) on chromosome 15,
and protein tyrosine phosphatase, receptor type, D (PTPRD) on
chromosome 9.31–33 The function of these genes is mainly related to
embryonic neuronal development, but how they relate to RLS or
PLMS is not known. Interestingly, in an Icelandic population,
Stefansson et al. found that there was a significant association between
an intronic variant on BTBD9 and having both RLS and PLMS.31
This association was present in persons who were PLMS positive and
RLS negative, but not RLS positive and PLMS negative, suggesting
that there was greater genetic association with PLMS rather than RLS.
More recent work has shown that variants within TOX3/BC034767,
MEIS1 (two unlinked loci), MAP2K5/SKOR1, and PTPRD as well as
BTBD9 are significantly associated with the presence of PLMS, and
that this association is only modestly reduced when adjusting for the
presence of RLS symptoms.34
Epidemiology
There are similarities in prevalence between RLS and PLMS, with
estimates of between 5% and 11% in the general population for both
entities.4,35,36 Prevalence of RLS has been evaluated in over 25
countries in more than 50 different epidemiologic studies.10 Far fewer
studies have estimated the prevalence of PLMS, even though there is
significant crossover of these two entities clinically. PLMS are seen in
up to 90% of persons with RLS, but they also occur in the absence of
RLS and are associated with other disorders, including sleep apnea,
stroke, and hypertension.1,37–39
In a sample of randomly chosen adults between the ages of 18 and
65 years, 7.6% of 592 individuals had PLMS recorded by
polysomnography (PSG). Interestingly, PLMS were significantly more
common in Caucasians than African Americans (9.3% vs. 4.3%).40
The prevalence of PLMS seems to increase in elderly people, as 45%
of 427 elderly people over 65 years were found to have PLMS on PSG;
a similar number of persons with PLMS was found in a community-
dwelling elderly female population.41,42 On the other hand, RLS may
begin at any age, but usually begins after the age of 40 years.43 Similar
to PLMS, RLS is most prevalent between the ages of 60 and 79 years.4
The prevalence of RLS is higher as PLMS frequency increases with
advancing age in RLS after the age of 15 and then again after age 65.7
There are conflicting data when considering the correlation between
PLMS frequency and severity of RLS, but, generally, PLMS frequency
is thought to increase as severity of RLS worsens.44 These similarities
in the epidemiology of RLS and PLMS further strengthen the
rationale to include PLMS measurement in the diagnosis of RLS.
Clinical relevance
The clinical relevance of RLS is far-reaching, affecting different
areas relevant to health. RLS often prevents the onset of sleep and is
commonly associated with insomnia.4 Sleep fragmentation consisting
of recurrent arousal from sleep is also commonly associated with RLS.1
This sleep disruption may be the basis for the increased prevalence of
depression in persons with RLS, in whom the odds of having
depression is increased more than two-and-a-half-fold compared to the
general population.45 Finally, there is growing interest in the potential
increased cardiovascular risk in persons with RLS. From two large
sleep epidemiology studies, frequent and severe RLS was associated
with a greater than twofold increased odds of prevalent cardiovascular
disease, which included myocardial infarction, angina, and having had
coronary revascularization.2,3 Some but not all longitudinal studies
have confirmed this relationship between RLS and incident cardio-
vascular disease.46–48
Clinical associations with PLMS seem to mirror those for RLS. Like
in RLS, sleep disruption associated with PLMS is well described. It is
Table 1. International Restless Legs Syndrome Study Group Consensus Diagnostic Criteria for RLS
1) An urge to move the legs usually but not always accompanied by, or felt to be caused by, uncomfortable and unpleasant
sensations in the legs.
2) The urge to move the legs and any accompanying unpleasant sensations begin or worsen during periods of rest or inactivity
such as lying down or sitting.
3) The urge to move the legs and any accompanying unpleasant sensations are partially or totally relieved by movement, such
as walking or stretching, at least as long as the activity continues.
4) The urge to move the legs and any accompanying unpleasant sensations during rest or inactivity only occur or are worse in
the evening or night rather than during the day.
5) The occurrence of the above features is not solely accounted for as symptoms primary to another medical or behavioral
condition (e.g., myalgia, venous stasis, leg edema, arthritis, leg cramps, positional discomfort, habitual foot tapping).
A. Chronic-persistent RLS/WED: symptoms when not treated would occur on average at least twice weekly for the past year.
B. Intermittent RLS/WED: symptoms when not treated would occur on average
Abbreviations: RLS, Restless Legs Syndrome; WED, Willis Ekbom Disease.
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common for arousal and limb movements to co-occur in a complex,
whereby PLMS may either precede or follow arousal.49,50 In addition
to their association with arousal, PLMS also coincide with discrete
surges in heart rate and blood pressure.51 These surges reach the order
of 20–30 mmHg for systolic blood pressure and 10 beats per minute
for heart rate, and occur with PLMS in both persons with RLS and
persons without RLS.51,52 These surges in blood pressure may underlie
the association (albeit not universally found) between RLS and
hypertension.53 In addition to these intermittent surges in blood
pressure, PLMS have recently been linked to diurnal hypertension.39
Like RLS, PLMS, especially when occurring with arousal, are
associated with incident cardiovascular disease.54 These findings
suggest that PLMS are the substrate which relates RLS to the clinical
entities of sleep disruption and cardiovascular disease.
Measurement of PLMS
PLMS consist of stereotypic movements made up of foot dorsi- and
plantar flexion to a greater extent than flexion–extension at the knee.55
Reflecting this pattern of movement, muscles involved in descending
order of frequency in PLMS are tibialis anterior, gastrocnemius, biceps
femoris, and rectus femoris. Rarely, arms are involved. Typically,
PLMS are detected by electromyography (EMG) during a sleep study
or PSG. In an in-laboratory sleep study, bilateral tibialis anterior EMG
electrodes are included as part of the standard montage. Using this
technology, PLMS appear as discrete, 0.5–5-second EMG bursts that
occur approximately every 20–40 seconds (Figure 1). Although PLMS
can be detected by EMG during overnight sleep study, the
determination of whether or not an individual has PLMS is not an
indication for PSG. So what are the other means by which PLMS can
be detected and measured?
Different sensors have been used to detect PLMS. Piezoelectric
sensors convert the energy of pressure differentials or acceleration into
an electrical signal. Piezoelectric sensors, placed around the anterior
tibialis, can be used to detect and measure PLMS. This sensor has been
used as part of a PSG montage to measure PLMS.54 But using this
sensor does not circumvent the problem of PSG not being indicated to
measure PLMS. Acceleration can also be detected using an accel-
erometer. Accelerometry is the basis for a PLMS detection device called
the PAM-RL (Philips-Respironics, Murrysville, PA). The PAM-RL
device is worn on either one or both ankles, and records movement data
over several hours or even days. Raw movement data can then be auto-
scored with software to determine the presence and frequency of PLMS.
Discussion
It is important to note that this subject of the utility of including PLMS to
increase specificity and sensitivity of RLS diagnosis has been studied
previously. Using expert diagnosis of RLS based upon IRLSSG criteria as
the gold standard, Benes et al.56 determined the additional predictive value
of using different ancillary features of RLS. By adding PLMS to IRLSSG
criteria, an additional 10% of the diagnostic variance was explained,
compared with 19% for the response to dopaminergic medication and
0.7% for RLS family history.56 In other words, PLMS can aid in making
the diagnosis of RLS, largely by increasing specificity.
Table 2 summarizes similarities shared between RLS and PLMS. In
summary, PLMS are seen in 80–90% of persons with RLS, but their
presence is neither sufficient nor necessary to diagnose RLS. In this
monograph, shared features of RLS and PLMS that span different
areas, including pathophysiology, genetics, pharmacology, and epide-
miology, have been described. Since PLMS are measurable or
objective, their inclusion among the diagnostic criteria of RLS, which
are completely subjective, would be complementary. In RLS diagnosis,
the issue of distinguishing the RLS mimic from RLS creates the most
confusion, and including PLMS in the RLS definition could help to
increase specificity. We, therefore, propose that PLMS be added as a
supplementary criterion for the diagnosis of RLS, so that when the
diagnosis is made on the basis of clinical symptomatology plus PLMS
that the designation be electro-clinical RLS.
This new designation of electro-clinical RLS is not intended to
replace the current diagnostic scheme. Nor is it advocated that RLS
not be diagnosed when PLMS are not assessed. The assessment for
Figure 1. Periodic LimbMovements during Sleep. Pictured is a 2-minute epoch that shows periodic limb movements during sleep (PLMS), which occur every
20–30 seconds. Electroencephalographic activations and accelerations in heart rate occur at the same time as PLMS.
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PLMS alone without concern for sleep-disordered breathing should
not prompt a nocturnal PSG. We also realize that different
technologies used to determine PLMS can be expensive, available
only in specialized centers, and are not available in areas or countries
where sleep medicine is underdeveloped. But, the addition of PLMS as
a supplementary criterion could be useful in cases where diagnosis is
unclear, or in research projects where proper diagnosis is desired at the
investigational level.
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